December 2, 1995European Heart Journal
The role of transgenic knockout models in defining the pathogenesis of viral heart disease
Key result
Transgenic knockout models reveal specific immune pathways driving viral myocarditis pathogenesis.
Why the study?
The molecular contributions of the virus, immune system, and myocytes in viral myocarditis pathogenesis require elucidation using transgenic knockout models.
Population
Transgenic knockout mouse models of viral myocarditis including IRF-1, CD4, and p56lck knockouts
Comparison
Knockout of specific immune molecules versus wild-type controls
Design
Review of transgenic knockout model studies
Authors
Discussion
Loading...
Member takes
Implication
May guide immune target identification in viral myocarditis; leaves open clinical translation from murine models.
Structured PICO
P
Population
Transgenic knockout models (e.g., IRF-1 knockout mouse, CD4 knockouts, p56lck knockouts) used for studying viral myocarditis
E
Exposure
Genetic knockout of specific immune system components (e.g., IRF-1, CD4, p56lck)
O
Outcome
Pathogenesis of viral myocarditis, including susceptibility to viral infection and mortality
Transgenic knockout models provide critical insights into the molecular pathogenesis of viral myocarditis by isolating the roles of specific immune system components.
Limitations
- Techniques for transgenic knockout models are technically challenging and time consuming
Cite This Study
Liu et al. (1995) conducted a review in Viral heart disease / myocarditis. Transgenic knockout models was evaluated. Transgenic knockout models, such as IRF-1, CD4, and p56lck knockout mice, provide unique insights into the molecular contributions of the immune system in the pathogenesis of viral myocarditis.